Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels ...

National Institutes of Health officials have urged scientists to remove all references to mRNA vaccine technology from their ...

This first-in-class approach utilizes a single 'all-in-one' mRNA design to simplify delivery for therapeutic applications, potentially addressing complex genetic diseases like Wilson's disease and ...

This acquisition combines Officinae Bio's AI-enabled mRNA design platforms with Maravai and TriLink BioTechnologies' leading drug substance manufacturing capabilities, providing customers ...

“By integrating our expertise in mRNA design and nanoparticle delivery with IPA’s cutting-edge antibody discovery and engineering capabilities, we can address longstanding challenges in ...